Keyword: Dr. Reddy’s Laboratories


Global Pharma Reduces Marketing Staff in India

21.03.2023 -

As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their...

Strategy & Management

Experts Statements: Ravi Venkataramanan, Dr. Reddy’s Laboratories

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...


Lilly Wins Alimta Appeal

23.08.2019 - US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories. The US...


Pfizer Loses Patent Appeal Against Allergan

17.10.2016 - Pifzer has lost its appeal of a UK patent dispute with Allergan over Lyrica, one of the US pharmaceutical giant blockbuster drugs, with annual global sales of around $5 billion. It...


Teva Wins US Nod for Allergan’s Generics

29.07.2016 - Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...